# FDA Inspection 1153219 - Octapharma Plasma Inc - September 14, 2021

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/6dfc43b0-5752-46b1-8bf1-452fefd8cccc
Source feed: FDA_Inspections

> FDA Inspection 1153219 for Octapharma Plasma Inc on September 14, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1153219
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2021-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1153219 - 2021-09-14](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/66a555c6-000a-4566-bf63-4b5c7f1069b1)
- [FDA Inspection 1009884 - 2017-03-24](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/04a518a2-d785-4aaa-a8c7-cb5ee6d39924)
- [FDA Inspection 909240 - 2015-01-08](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/c074d119-cd27-4242-baa4-9e0f46b6476e)
- [FDA Inspection 820739 - 2013-02-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/7799b5ce-3c60-4219-8105-932bbdbd455c)
- [FDA Inspection 732180 - 2011-06-07](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/afe68971-b021-4bff-a967-d9e91ee6093c)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/16e84dc9-eaf1-4e95-94c0-9e214ed2d5f1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d